World's first RSV vaccine
After 60 years of research, the world's first RSV vaccine for older adults has been cleared in the US. Bloomberg's Suzi Ring reports from GSK's factory floor.
After 60 years of research, the world's first RSV vaccine for older adults has been cleared in the US. Bloomberg's Suzi Ring reports from GSK's factory floor.
Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first, the Centers for Disease Control and Prevention says.
Get up-to-the-minute news sent straight to your device.